BRCA2 and breast carcinoma: Of 160 cancers with BRCA1/2 mutations, LOH was detected in 90% cases of BRCA1 positivity and 54% cases of BRCA2 positivity in breast cancer, and in 93% cases of BRCA1 positivity and 84% cases of BRCA2 positivity in ovarian cancer.